Stock & Company Details
Innoviva Inc $INVA
Price:
N/A
N/A
72M
$1.5B
52 Week High:
N/A
10 Day Average Volume:
N/A
3.59
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
INVA technical indicators
Latest Innoviva Inc (INVA) indicator readings as of 2026-10-29.
INVA's 14-day RSI is 54.9, in neutral territory. At $21.31 it is trading 2.6% below its 200-day moving average of $21.88, and above its 50-day average of $20.99. Price sits near the upper Bollinger Band ($20.49 to $21.44). ADX reads 11.6, indicating a range-bound market rather than a trend.
Overview
Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline.
Finance Bot
Ask your questions
Start by typing a question below.
